- Research works
- 78 ▼ 72% vs 2018-21
- Citations
- 2.6k 32.6 per fractional work
- Top-10% rate
- 10.9% all institutions 10.0%
- Open access
- 29% world 40%
- International
- 34% world 18%
Not ranked overall: Symphogen (Denmark) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Symphogen (Denmark) work in?
In all years, 57% of research at Symphogen (Denmark) is in Health Sciences, 39% in Life Sciences. Its largest fields are Medicine (57%), Biochemistry, Genetics and Molecular Biology (30%), Immunology and Microbiology (8%). It does 2.3× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 3 domains and 12 fields, with their numbers
- Health Sciences4456.6%
- Medicine4456.6%
- Life Sciences3038.8%
- Physical Sciences44.6%
- Chemistry22.4%
- Engineering10.9%
- Environmental Science10.7%
- Computer Science00.3%
- Physics and Astronomy00.2%
- Materials Science00.1%
- Mathematics00.0%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at Symphogen (Denmark)?
Ranked on the quality score, Ivan David Horak, Mikkel Wandahl Pedersen and John Sørensen Haurum lead among researchers whose main affiliation is Symphogen (Denmark).
- 1
Ivan David Horak
Denmark · #144,630 worldwide 18k citations · 458 works
- 2
Mikkel Wandahl Pedersen
Denmark · #514,980 worldwide 3.2k citations · 160 works
- 3
John Sørensen Haurum
Denmark · #674,338 worldwide 2.6k citations · 65 works
- 4
Michael Kragh
Denmark · #688,224 worldwide 2.6k citations · 184 works
- 5
Helle Jane Jacobsen
Denmark · #831,207 worldwide 1.4k citations · 62 works
- 6
Klaus Koefoed
Denmark · #937,440 worldwide 1.9k citations · 70 works
- 7
Johan Lantto
Denmark · #1,593,991 worldwide 1.6k citations · 119 works
- 8
Per‐Johan Meijer
Denmark · #1,600,643 worldwide 1.8k citations · 22 works
- 9
Dietmar Weilguny
Denmark · #1,642,274 worldwide 1.1k citations · 57 works
- 10
Thomas T. Poulsen
Denmark · #1,677,089 worldwide 903 citations · 116 works
Which keywords describe research at Symphogen (Denmark)?
By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Chemotherapy, Monoclonal Antibody and Breast Cancer.
- Foxp3
- Macrophages
- Fluorouracil
- Molecular Subtypes
- Cetuximab
- Radiopharmaceuticals
- Recombinant Protein
- EGFR Mutations
- Clinical Trials
- Immune System
- Inflammation
- PET Imaging
- Stability
- Cancer
- Targeted Therapy
- Biopharmaceuticals
- Breast Cancer
- Chemotherapy
- Antibody Engineering
- Monoclonal Antibodies
- Glycosylation
- Therapeutic Antibodies
- Fc Receptors
- Monoclonal Antibody
- HER2
- Recombinant Proteins
- Immunogenicity
- Protein Aggregation
- Tumor Microenvironment
- Angiogenesis
- Glycans
- Immunotherapy
- ALK Inhibitors
- Mammalian Cells
- Radioimmunotherapy
- Autoimmunity
- Gene Therapy
- Tumor Regression
- KRAS Mutations
- Cancer Immunotherapy
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Glycosylation22▲ 124×3 topics
- Monoclonal Antibodies21▲ 184×3 topics
- Therapeutic Antibodies20▲ 202×2 topics
- Antibody Engineering15▲ 196×1 topic
- Fc Receptors15▲ 196×1 topic
- Chemotherapy11▲ 20×6 topics
- Monoclonal Antibody11▲ 198×2 topics
- Breast Cancer8▲ 37×1 topic
- HER28▲ 341×1 topic
- Biopharmaceuticals7▲ 124×3 topics
- Recombinant Proteins6▲ 152×2 topics
- Targeted Therapy6▲ 38×5 topics
- Immunogenicity5▲ 132×2 topics
- Cancer5▲ 4.7×7 topics
- Protein Aggregation5▲ 82×1 topic
- Stability5▲ 34×1 topic
- Tumor Microenvironment4▲ 16×6 topics
- PET Imaging4▲ 24×3 topics
- Angiogenesis4▲ 12×4 topics
- Inflammation4▲ 2.0×8 topics
- Glycans4▲ 54×1 topic
- Immune System4▲ 14×1 topic
- Immunotherapy3▲ 6.6×7 topics
- Clinical Trials3▲ 6.4×4 topics
- ALK Inhibitors3▲ 68×1 topic
- EGFR Mutations3▲ 68×1 topic
- Mammalian Cells3▲ 87×1 topic
- Recombinant Protein3▲ 87×1 topic
- Radioimmunotherapy2▲ 80×1 topic
- Radiopharmaceuticals2▲ 80×1 topic
- Autoimmunity2▲ 15×2 topics
- Cetuximab2▲ 35×2 topics
- Gene Therapy2▲ 11×3 topics
- Molecular Subtypes2▲ 34×2 topics
- Tumor Regression2▲ 33×2 topics
- Fluorouracil2▲ 86×1 topic
- KRAS Mutations2▲ 86×1 topic
- Macrophages2▲ 15×2 topics
- Cancer Immunotherapy2▲ 18×2 topics
- Foxp32▲ 31×1 topic
Which research topics does Symphogen (Denmark) publish most on?
By volume in 2022-now: Protein purification and stability, Advanced Proteomics Techniques and Applications, Viral Infectious Diseases and Gene Expression in Insects and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Protein purification and stability Molecular Biology 1 works
- 2 Advanced Proteomics Techniques and Applications Spectroscopy 1 works
- 3 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 5 Mass Spectrometry Techniques and Applications Spectroscopy 0 works
- 6 HER2/EGFR in Cancer Research Oncology 0 works
- 7 Advanced Biosensing Techniques and Applications Molecular Biology 0 works
- 8 Biosimilars and Bioanalytical Methods Immunology 0 works
- 9 CAR-T cell therapy research Oncology 0 works
- 10 Vascular Malformations and Hemangiomas Surgery 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Symphogen (Denmark)'s research output changed?
Output in 2022-2025 was 72% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Symphogen (Denmark) as a percentage of every work published that year, 0.0000018% in 2024.
Fractional works of Symphogen (Denmark) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Ballerup Municipality
- Leo Pharma (Denmark)
- Kommunedata (Denmark)
- Center for Clinical & Basic Research
- GN Store Nord (Denmark)
- Danish Defence Acquisition and Logistics Organization
- NsGene (Denmark)
- Saniona (Denmark)
- William Demant Holding (Denmark)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Symphogen (Denmark). Posts are plain text and can be reported.